FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

714213006: Product containing bevacizumab in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3298414018 Parenteral form bevacizumab (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
3298581018 Parenteral form bevacizumab en Synonym Inactive Only initial character case insensitive SNOMED CT core module
3488570016 Product containing bevacizumab in parenteral dosage form (medicinal product form) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3497622016 Bevacizumab in parenteral dosage form en Synonym Inactive Entire term case insensitive SNOMED CT core module
3497623014 Product containing bevacizumab in parenteral dosage form en Synonym Inactive Entire term case insensitive SNOMED CT core module
3708804013 Product containing bevacizumab in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3708805014 Bevacizumab-containing product in parenteral dose form en Synonym Active Entire term case insensitive SNOMED CT core module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing bevacizumab in parenteral dose form (medicinal product form) Is a Product containing bevacizumab true Inferred relationship Existential restriction modifier
Product containing bevacizumab in parenteral dose form (medicinal product form) Is a Product manufactured as parenteral dose form true Inferred relationship Existential restriction modifier
Product containing bevacizumab in parenteral dose form (medicinal product form) Has active ingredient Bevacizumab true Inferred relationship Existential restriction modifier 1
Product containing bevacizumab in parenteral dose form (medicinal product form) Has manufactured dose form Parenteral dose form true Inferred relationship Existential restriction modifier
Product containing bevacizumab in parenteral dose form (medicinal product form) Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bevacizumab 25mg/mL injection solution 4mL vial Is a False Product containing bevacizumab in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier
Bevacizumab 25mg/mL injection solution 16mL vial Is a False Product containing bevacizumab in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely bevacizumab 400 milligram/16 milliliter conventional release solution for injection vial Is a False Product containing bevacizumab in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely bevacizumab 100 milligram/4 milliliter conventional release solution for injection vial Is a False Product containing bevacizumab in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing only bevacizumab in parenteral dose form (medicinal product form) Is a True Product containing bevacizumab in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start